New eye scan could spot early signs of wet AMD returning
NCT ID NCT03803631
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested a new, non-invasive eye scan called OCT angiography to see if it can better detect changes in abnormal blood vessels in people with wet age-related macular degeneration (AMD) who are being treated with Eylea. Researchers followed 49 patients to compare the new scan with standard imaging. The goal was to find early signs that the disease might be coming back, which could help doctors adjust treatment sooner.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors detect early signs of wet AMD recurrence using a non-invasive imaging test, potentially improving treatment timing.
What could go wrong
This is a small, completed observational study (49 participants) that does not test a new treatment. The findings may not change current practice without larger validation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHI de Créteil
Créteil, 94000, France
-
Centre Ophtalmologique d'Imagerie et de Laser,
Paris, 75015, France
-
Hôpital La Croix Rousse
Lyon, 69004, France
-
Hôpital Lariboisière, APHP
Paris, 75010, France
-
Hôpital Pellegrin, CHU de Bordeaux
Bordeaux, 33000, France